Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2309 (LINC02309)
- Target
- LINC02309
- Molecular classification
- Long non-coding RNA (lncRNA), long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2309 (LINC02309) is a human gene transcribed into a long non-coding RNA (lncRNA) but does not code for protein. It belongs to the lincRNA subclass, defined as long (>200 nucleotides), intergenic transcripts that do not overlap annotated protein-coding genes[3][7]. LINC02309 has been cataloged in gene databases (GeneCards, NCBI Gene, Ensembl) but, as of now, has no specific described function, no disease association, and no known roles as a therapeutic target or biomarker. LincRNAs more generally are involved in diverse processes such as chromatin remodeling and fine-tuning gene expression, usually in a tissue-specific manner[3][7], but these general features cannot be ascribed to LINC02309 individually without further supporting evidence.
- Other names
- LINC02309ENSG00000258994 (Ensembl gene ID)105370607 (NCBI Gene ID)
02
Biological functions
No specific function reported for LINC02309 itself. However, lincRNAs in general can engage in chromatin remodeling, genome architecture regulation, RNA stabilization, and transcriptional regulation, including enhancer-like activity.
03
Disease associations
No disease associations or roles are currently reported for LINC02309 specifically. While lincRNAs broadly have roles in cancer, developmental processes, and regulation of gene expression, no such role is mapped for LINC02309 as of current annotations.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2309 (LINC02309).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2309 (LINC02309).